Hafrun Fridriksdottir, Executive VP, Global R&D at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 19,030 shares at $10.57 ($201K) on 2021-03-04, disclosed to the SEC on 2021-03-08.
Seasonal sale ($201k) by Executive VP, Global R&D — this insider has traded TEVA in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.57 | 9,515 | $101K | 50.0% |
| 2 | $10.57 | 9,515 | $101K | 50.0% |
| Total | $10.57 avg | 19,030 | $201K | 100% |
| Filing → |
| TEVA | SELL | 2022-03-02 | $124K | — | Filing → |
| TEVA | SELL | 2022-02-10 | $111K | — | Filing → |
| TEVA | SELL | 2021-08-12 | $1.0M | — | Filing → |